{ }
The Global Uveitis Treatment market is projected to grow from USD 725 million in 2024 to USD 1.28 billion by 2032, with a CAGR of 8.5%. The study covers various treatment types, including corticosteroids and biologic agents, and offers customization options for regional and application-specific analysis. Key players include Novartis, Pfizer, and AbbVie, with North America leading the market and Asia-Pacific identified as the fastest-growing region.
The Global Fermented Beverages market, valued at 860 billion USD in 2024, is projected to reach 1.3 trillion USD by 2032, growing at a CAGR of 6.4%. The market analysis covers major regions including North America, Europe, and Asia-Pacific, with customization options available for specific countries and applications. Key players include Apple, Microsoft, and Nestlé, with insights into market dynamics, competitive landscape, and growth drivers such as lifestyle changes and technological advancements in fermentation.
YTL Power International Bhd led the market as the top gainer, rising 42 sen to close at RM4.08, followed closely by YTL Corporation Bhd, which increased by 41 sen to RM2.55. In contrast, Nestle (Malaysia) Bhd was the top decliner, losing RM2.00 to settle at RM97.00.
Under Armour, Inc. specializes in developing, marketing, and distributing branded sportswear, footwear, and accessories for men, women, and youth. The company operates across four regions: North America, EMEA, Asia-Pacific, and Latin America, utilizing both wholesale and direct-to-consumer sales channels. In the EMEA region, sales are primarily through independent wholesalers and e-commerce, while in Asia, distribution includes partnerships and online platforms.
Under Armour, Inc. has received a Buy rating from UBS. The company specializes in the development, marketing, and distribution of branded athletic performance apparel, footwear, and accessories for men, women, and youth across various global markets, including North America, EMEA, Asia-Pacific, and Latin America. Its products are sold through wholesale and direct-to-consumer channels, as well as e-commerce platforms and physical stores.
Under Armour, Inc. has received a Buy rating from UBS. The company specializes in the development, marketing, and distribution of branded athletic performance apparel, footwear, and accessories for men, women, and youth across various global markets, including North America, EMEA, Asia-Pacific, and Latin America. Its products are sold through wholesale and direct-to-consumer channels, as well as e-commerce platforms and physical stores.
Pi Network has issued critical warnings urging users to rely solely on official channels and to use the authentic Pi Wallet within the Pi Browser to avoid scams. With 14 million users verified and a target of 15 million by December 31, the project faces skepticism over its delayed mainnet launch and ongoing controversies. The team plans to unveil the mainnet roadmap in December, aiming to clarify the timeline for buying and selling Pi tokens.
Most Asian stocks declined ahead of the U.S. Federal Reserve's interest rate decision, with Chinese shares falling due to disappointing retail sales data, raising concerns about the economy's recovery. Japan's market remained stable as the Bank of Japan is expected to maintain current rates, while South Korea's index showed little change following the president's impeachment. Overall, investor sentiment was cautious globally as markets awaited clarity from the Fed amidst persistent inflation concerns.
The Global Bromhexine Tablet market is projected to grow from USD 875.5 million in 2023 to USD 1,131.7 million by 2032, with a CAGR of 3.7% from 2024 to 2032. This growth is driven by the rising prevalence of respiratory disorders and increasing demand for expectorants. Key players include Sanofi, Teva, and Boehringer Ingelheim, with market segmentation covering applications, types, and distribution channels across various regions.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.